Mauro Bernardi, Stefano Gitto, Maurizio Biselli  Journal of Hepatology 

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 61, Issue 2, Pages (August 2014)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Volume 66, Issue 3, Pages (March 2017)
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
MELD: the holy grail of organ allocation?
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
m-TOR inhibitors: What role in liver transplantation?
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis  Wichit Srikureja,
Brain stimulation as a neuromodulatory epilepsy therapy
Comparing paediatric intravenous phenytoin doses using physiologically based pharmacokinetic (PBPK) modelling software  Hannah Batchelor, Richard Appleton,
m-TOR inhibitors: What role in liver transplantation?
Volume 68, Issue 5, Pages (May 2018)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
The impact of hepatitis E in the liver transplant setting
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Pulmonary contraindications, indications and MELD exceptions for liver transplantation: A contemporary view and look forward  Michael J. Krowka, Russell.
Immigration and viral hepatitis
Marcus-Alexander Wörns, Peter Robert Galle  Journal of Hepatology 
Liver transplantation for hepatitis B virus-related liver disease: Indications, prevention of recurrence and results  Bruno Roche, Didier Samuel  Journal.
Living donor liver transplantation: is the hype over?
What lessons have we learned in pediatric liver transplantation?
Cortical stimulation parameters for functional mapping
Reply to: “DCD consensus and futility in liver transplantation”
How important is the seizure onset zone for seizure dynamics?
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
The place of downstaging for hepatocellular carcinoma
Volume 58, Issue 3, Pages (March 2013)
AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary.
Comparing paediatric intravenous phenytoin doses using physiologically based pharmacokinetic (PBPK) modelling software  Hannah Batchelor, Richard Appleton,
Familial amyloid polyneuropathy and liver transplantation
Hepatitis C core protein – The “core” of immune deception?
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Volume 44, Issue 1, Pages (January 2006)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Management of cirrhosis due to chronic hepatitis C
Who should get a liver graft?
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 57, Issue 5, Pages (November 2012)
Paul C. Adams, James C. Barton  Journal of Hepatology 
Portal vein thrombosis, cirrhosis, and liver transplantation
Immigration and viral hepatitis
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
The impact of intestinal microflora on serum bilirubin levels
Volume 63, Issue 1, Pages (July 2015)
The posterior cerebellum, a new organ at risk?
The use of hemospray in portal hypertensive bleeding; a case series
Chronic hepatitis B in children and adolescents
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice  Paolo Angeli, Pere Gines 
Volume 66, Issue 3, Pages (March 2017)
Volume 62, Issue 3, Pages (March 2015)
m-TOR inhibitors: What role in liver transplantation?
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Donor-recipient matching: Myths and realities
Comment on the article “Age and liver transplantation”
MELD: the holy grail of organ allocation?
Volume 135, Issue 5, Pages (November 2008)
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Outcomes in liver transplantation: Does sex matter?
Reversion of disease manifestations after HCV eradication
Presentation transcript:

The MELD score in patients awaiting liver transplant: Strengths and weaknesses  Mauro Bernardi, Stefano Gitto, Maurizio Biselli  Journal of Hepatology  Volume 54, Issue 6, Pages 1297-1306 (June 2011) DOI: 10.1016/j.jhep.2010.11.008 Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Unadjusted death rates per 1000 patient-years of OLT candidates on the waiting list in the pre-MELD era (light blue) and in the post-MELD era (dark blue) in the United States (data from Ref. [16]). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) Journal of Hepatology 2011 54, 1297-1306DOI: (10.1016/j.jhep.2010.11.008) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Median waiting time to OLT after the implementation of MELD in 2002 in the United States (data from Ref. [16]). Journal of Hepatology 2011 54, 1297-1306DOI: (10.1016/j.jhep.2010.11.008) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 3 ROC curves for best predictors of dropout from the waiting list with respect to standard MELD at 3 and 6 months (data from Ref. [101]). Despite both iMELD and MELD-Na showed a higher AUC in respect to standard MELD at 3months, the comparison between AUCs showed that only MELD-Na had a significantly better prognostic power than the standard MELD, because of the very small standard error (0.018) in the difference between the areas (0.039). Journal of Hepatology 2011 54, 1297-1306DOI: (10.1016/j.jhep.2010.11.008) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2011 54, 1297-1306DOI: (10. 1016/j. jhep. 2010 Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2011 54, 1297-1306DOI: (10. 1016/j. jhep. 2010 Copyright © 2010 European Association for the Study of the Liver Terms and Conditions